Literature DB >> 27644932

Kidney cancer: Papillary features predict survival in ncRCC.

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27644932     DOI： 10.1038/nrurol.2016.186

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma.

Authors:  Martin H Voss; Ana M Molina; Ying-Bei Chen; Kaitlin M Woo; Joshua L Chaim; Devyn T Coskey; Almedina Redzematovic; Patricia Wang; William Lee; S Duygu Selcuklu; Chung-Han Lee; Michael F Berger; Satish K Tickoo; Victor E Reuter; Sujata Patil; James J Hsieh; Robert J Motzer; Darren R Feldman
Journal:  J Clin Oncol       Date:  2016-11-10       Impact factor: 44.544

Review 2.  Misdiagnosis of clear cell renal cell carcinoma.

Authors:  Vladimir A Valera; Maria J Merino
Journal:  Nat Rev Urol       Date:  2011-05-17       Impact factor: 14.432
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.